Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mixed cryoglobulinemia].

B Tribout, J Delobel, P F Westeel

    La Revue Du Praticien
    |October 11, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Mixed cryoglobulinemia, a condition involving abnormal proteins in the blood, presents in two main types. While often linked to other health issues, essential mixed cryoglobulinemia involves systemic vasculitis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nonadrenergic and noncholinergic arterial dilatation and venoconstriction are mediated by calcitonin gene-related peptide1 and neurokinin-1 receptors, respectively, in the mesenteric vasculature of the rat after perivascular nerve stimulation.

    The Journal of pharmacology and experimental therapeutics·1992
    Same author

    Studies of 300-microns microcapsules: I. Use of arginine esterase release by microencapsulated prostatic cells as a measure of membrane permeability.

    Transplantation proceedings·1992
    Same author

    Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.

    The Journal of pharmacology and experimental therapeutics·1992
    Same author

    Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.

    The Journal of pharmacology and experimental therapeutics·1992
    Same author

    Neuropeptide Y inhibits alpha-MSH release from rat hypothalamic slices through a pertussis toxin-sensitive G protein.

    Brain research·1992
    Same author

    Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy.

    Kidney international·1992
    Same journal

    [Prolonged fever].

    La Revue du praticien·2026
    Same journal

    [Lower gastrointestinal bleeding].

    La Revue du praticien·2026
    Same journal

    [Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

    La Revue du praticien·2026
    Same journal

    [A history of child abuse intervention in the West].

    La Revue du praticien·2026
    Same journal

    [Agranulocytose médicamenteuse].

    La Revue du praticien·2026
    Same journal

    [Patient education in heart failure].

    La Revue du praticien·2026
    See all related articles

    Area of Science:

    • Immunology
    • Rheumatology
    • Nephrology

    Context:

    • Mixed cryoglobulinemia is classified into two types based on immunoglobulin composition: Type II (polyclonal IgG with monoclonal IgM) and Type III (polyclonal IgG with polyclonal IgM).
    • Identifying the underlying cause of cryoglobulinemia, which can include hematologic, autoimmune, infectious, or hepatic disorders, is crucial, though it may be delayed in some cases.
    • Approximately 30% of cryoglobulinemia cases are deemed essential, meaning no specific cause can be identified.

    Purpose:

    • To delineate the classification, clinical manifestations, and biological markers of mixed cryoglobulinemia.
    • To highlight the characteristics of essential mixed cryoglobulinemia, also known as Meltzer and Franklin syndrome.

    Summary:

    • Mixed cryoglobulinemia involves abnormal protein complexes (cryoglobulins) that precipitate in the cold.

    Related Experiment Videos

  • Type II involves monoclonal IgM, while Type III involves polyclonal IgM.
  • Common clinical findings include skin rash, joint pain, neuropathy, and glomerulonephritis.
  • Biological hallmarks include anemia, positive rheumatoid factor, and low complement levels.
  • Essential mixed cryoglobulinemia is defined by systemic vasculitis affecting small and medium-sized vessels.

    • Impact:

    • Improved understanding of mixed cryoglobulinemia classification and associated conditions.
    • Facilitates earlier diagnosis and management of patients with cryoglobulinemia.
    • Contributes to the characterization of systemic vasculitis in essential mixed cryoglobulinemia.